OU biomedical engineering professor takes lead to conduct study to develop a COVID-19 vaccine booster

An OU biomedical engineering professor is conducting a study to help develop a booster for a COVID-19 vaccine.

According to a press release from the Gallogly College of Engineering, Wei R. Chen will lead researchers in the study, which is a collaboration with Immunophotonics, Inc., a biotech company located in St. Louis, Missouri. Immunophotonics is a private biotechnology company that is developing a proprietary carbohydrate polymer (IP-001), a potential treatment for a wide variety of tumor indications, for use.

The study will determine the effectiveness of the drug IP-00 in producing immune responses as a booster for a COVID-19 vaccine.

“I am thankful for the confidence Immunophotonics has placed in me to lead this timely and important project during the COVID-19 outbreak,” Chen said in the release. “Being part of the possible solution to strengthen vaccine outcomes is a rewarding endeavor.”

Read the full story from OUDaily here.